Mixture Nitrous Oxide - Oxygen 50-50% in Transrectal Prostate Biopsy Guided by Ultrasound
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
Introduction: Transrectal ultrasound-guided prostate biopsy (TUPB) is the gold standard
diagnostic tool for prostate cancer and, though may be well tolerated for some patients,
about 65 to 90% of then still complain of discomfort, weather associated or not to pain.
Therefore, as a manner of improvement in visual analogic pain score (VAS) and satisfaction
between those patients, the aim of this study is to propose the gas mixture N2O-O2 50-50%, as
a non-invasive, safe and cost-effective method to deliver analgesia and/or sedation, without
the need for an anesthesiologist.
Materials and methods: A randomized clinical trial, simple blind, which took place in
Hospital Universitário Antônio Pedro, Niteroi, RJ, within two groups containing 42 patients
each, divided in conventional (C), which received 100% oxygen and nitrous oxide (NO), which
received inhalation of the mixture N2O-O2 50-50% from a self-demand valve during exam. They
were accessed for pain with VAS, answered a satisfaction task and were recorded about
collateral side effects.